These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 1685561

  • 21. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O, Mohringe B, Fowler CJ.
    J Neural Transm; 1987; 69(3-4):163-77. PubMed ID: 2957465
    [Abstract] [Full Text] [Related]

  • 22. [Effect of the atypical neuroleptics carbidine and sulpiride on dopamine biosynthesis in the synaptosomes of the nucleus accumbens septi in rats].
    Kudrin VS, Hetey L, Morgenshtern R, Raevskiĭ KS, Olssner W.
    Farmakol Toksikol; 1987; 50(2):16-20. PubMed ID: 2884129
    [Abstract] [Full Text] [Related]

  • 23. Does brain 3,4-dihydroxyphenylacetic acid reflect dopamine release?
    Soares-da-Silva P.
    J Pharm Pharmacol; 1987 Feb; 39(2):127-9. PubMed ID: 2881997
    [Abstract] [Full Text] [Related]

  • 24. Remoxipride and raclopride differ from metoclopramide by their effects on striatal dopamine release and biosynthesis in rats.
    Guinetdinov RR, Bogdanov MB, Kudrin VS, Rayevsky KS.
    Neuropharmacology; 1994 Feb; 33(2):215-9. PubMed ID: 7913539
    [Abstract] [Full Text] [Related]

  • 25. Effects of apomorphine on in vivo release of dopamine and its metabolites in the prefrontal cortex and the striatum, studied by a microdialysis method.
    Ozaki N, Nakahara D, Miura H, Kasahara Y, Nagatsu T.
    J Neurochem; 1989 Dec; 53(6):1861-4. PubMed ID: 2809596
    [Abstract] [Full Text] [Related]

  • 26. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.
    Santiago M, Westerink BH.
    J Neurochem; 1991 Sep; 57(3):738-47. PubMed ID: 1677674
    [Abstract] [Full Text] [Related]

  • 27. Dopamine re-uptake inhibitors show inconsistent effects on the in vivo release of dopamine as measured by intracerebral dialysis in the rat.
    Westerink BH, Damsma G, De Vries JB, Koning H.
    Eur J Pharmacol; 1987 Mar 17; 135(2):123-8. PubMed ID: 3582491
    [Abstract] [Full Text] [Related]

  • 28. [Effect of the atypical neuroleptics karbidin and sulpiride on the synaptosomal tyrosine hydroxylase of the corpus striatum of rats].
    Meos AA, Kudrin VS, Raevskiĭ KS.
    Biull Eksp Biol Med; 1984 Sep 17; 98(9):305-8. PubMed ID: 6148973
    [Abstract] [Full Text] [Related]

  • 29. On the relation between haloperidol-induced alterations in DA release and DA metabolism in rat striatum.
    Moleman P, Bruinvels J, van Valkenburg CF.
    Life Sci; 1978 Aug 14; 23(6):611-5. PubMed ID: 692284
    [No Abstract] [Full Text] [Related]

  • 30. Regional effects of neuroleptics on dopamine metabolism and dopamine-sensitive adenylate cyclase activity.
    Scatton B, Bischoff S, Dedek J, Korf J.
    Eur J Pharmacol; 1977 Aug 15; 44(4):287-92. PubMed ID: 19266
    [Abstract] [Full Text] [Related]

  • 31. Involvement of striatal dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in the hypothermia and catalepsy induced by haloperidol.
    Massotti M.
    Pharmacol Res Commun; 1977 Apr 15; 9(4):381-9. PubMed ID: 559310
    [No Abstract] [Full Text] [Related]

  • 32. Interstitial 3-methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study.
    Brown EE, Damsma G, Cumming P, Fibiger HC.
    J Neurochem; 1991 Aug 15; 57(2):701-7. PubMed ID: 1906527
    [Abstract] [Full Text] [Related]

  • 33. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
    Gray AM, Connick JH.
    Eur J Pharmacol; 1998 Dec 04; 362(2-3):127-36. PubMed ID: 9874162
    [Abstract] [Full Text] [Related]

  • 34. Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover.
    Lerner P, Nosé P, Gordon EK, Lovenberg W.
    Science; 1977 Jul 08; 197(4299):181-3. PubMed ID: 17917
    [Abstract] [Full Text] [Related]

  • 35. Regulation of dopamine release and metabolism in rat striatum in vivo: effects of dopamine receptor antagonists.
    Rayevsky KS, Gainetdinov RR, Grekhova TV, Sotnikova TD.
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec 08; 19(8):1285-1303. PubMed ID: 8868210
    [Abstract] [Full Text] [Related]

  • 36. On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs.
    Waldmeier PC, Maître L.
    J Neurochem; 1976 Aug 08; 27(2):589-97. PubMed ID: 989496
    [No Abstract] [Full Text] [Related]

  • 37. Effect of varying the ionic concentration of a microdialysis perfusate on basal striatal dopamine levels in awake rats.
    Osborne PG, O'Connor WT, Ungerstedt U.
    J Neurochem; 1991 Feb 08; 56(2):452-6. PubMed ID: 1988549
    [Abstract] [Full Text] [Related]

  • 38. YM-09151-2 but not l-sulpiride induces transient dopamine release in rat striatum via a tetrodotoxin-insensitive mechanism.
    Tomiyama K, Noguchi M, Koshikawa N, Kobayashi M.
    J Neurochem; 1993 May 08; 60(5):1690-5. PubMed ID: 8473891
    [Abstract] [Full Text] [Related]

  • 39. Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration.
    Scatton B.
    Eur J Pharmacol; 1977 Dec 15; 46(4):363-9. PubMed ID: 590344
    [Abstract] [Full Text] [Related]

  • 40. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
    Meltzer HY, Chai BL, Thompson PA, Yamamoto BK.
    J Pharmacol Exp Ther; 1994 Mar 15; 268(3):1452-61. PubMed ID: 8138957
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.